Literature DB >> 3321914

Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations.

B Rippe1, B Haraldsson.   

Abstract

Treating the blood-tissue barrier as a two-pore membrane the separate fluid and solute fluxes occurring across 'small pores' and 'large pores' were modelled in continuous capillaries employing two-pore equations for the calculations together with the non-linear flux equation and theories for restricted diffusion and for the reflection coefficient (sigma). The two-pore equations derived proved useful for analyses of transvascular protein flux data obtained at low as well as at high filtration rates. These equations were applied to lymphatic protein flux data from dog paw (Renkin et al. 1977a, b) and to tracer albumin uptake data from rat skeletal muscle (Rippe et al. 1979). For both sets of data the small- and large-pore radii became closely similar, 44 vs. 45 A and 240 vs. 225 A, which also holds for the large-pore fractions of hydraulic conductivity (0.097 vs. 0.056). The main result of this analysis is that the passage of macromolecules normally occurring across the microvascular walls is almost entirely convective, and hence, dependent on the transmural hydrostatic and oncotic pressure gradients and on the hydraulic conductivity. For example, 75-90% of the transvascular passage of albumin was found to be due to convection through large pores at normal lymph flows, the remaining portion being mainly due to diffusion across small pores. Solutes larger than albumin were almost exclusively transported by convection across large pores. Two-pore heterogeneity was found to explain the previously observed variations of the apparent overall large solute diffusion capacity (PSapp) and the overall reflection coefficient (sigma f) with filtration rate and also previous overestimations of PS. Furthermore, the present results were not compatible with protein transport across any 'non-hydraulically conductive capillary pathways' as previously postulated from the lymphatic protein flux data analysed here (Renkin 1985).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321914     DOI: 10.1111/j.1748-1716.1987.tb08257.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  29 in total

1.  Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery.

Authors:  Deirdre P McIntosh; Xiang-Yang Tan; Phil Oh; Jan E Schnitzer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.

Authors:  Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-15       Impact factor: 2.745

4.  Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory.

Authors:  Armin Sepp; Alienor Berges; Andrew Sanderson; Guy Meno-Tetang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-01-11       Impact factor: 2.745

5.  A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptide.

Authors:  Elliot Offman; Andrea N Edginton
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-02-04       Impact factor: 2.745

6.  Effects of the FcRn developmental pharmacology on the pharmacokinetics of therapeutic monoclonal IgG antibody in pediatric subjects using minimal physiologically-based pharmacokinetic modelling.

Authors:  Deni Hardiansyah; Chee Meng Ng
Journal:  MAbs       Date:  2018-07-30       Impact factor: 5.857

Review 7.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

8.  Concomitant bidirectional transport during peritoneal dialysis can be explained by a structured interstitium.

Authors:  Joanna Stachowska-Pietka; Jacek Waniewski; Michael F Flessner; Bengt Lindholm
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-03-04       Impact factor: 4.733

9.  Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids.

Authors:  Greg M Thurber; K Dane Wittrup
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 10.  1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors.

Authors:  R K Jain
Journal:  Ann Biomed Eng       Date:  1996 Jul-Aug       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.